Details
Stereochemistry | ABSOLUTE |
Molecular Formula | 5C12H22O11.C6H11O7.2Fe.Na.3O |
Molecular Weight | 2089.308 |
Optical Activity | UNSPECIFIED |
Defined Stereocenters | 49 / 49 |
E/Z Centers | 0 |
Charge | 0 |
SHOW SMILES / InChI
SMILES
[O--].[O--].[O--].[Na+].[Fe+3].[Fe+3].OC[C@@H](O)[C@@H](O)[C@H](O)[C@@H](O)C([O-])=O.OC[C@H]1O[C@@](CO)(O[C@H]2O[C@H](CO)[C@@H](O)[C@H](O)[C@H]2O)[C@@H](O)[C@@H]1O.OC[C@H]3O[C@@](CO)(O[C@H]4O[C@H](CO)[C@@H](O)[C@H](O)[C@H]4O)[C@@H](O)[C@@H]3O.OC[C@H]5O[C@@](CO)(O[C@H]6O[C@H](CO)[C@@H](O)[C@H](O)[C@H]6O)[C@@H](O)[C@@H]5O.OC[C@H]7O[C@@](CO)(O[C@H]8O[C@H](CO)[C@@H](O)[C@H](O)[C@H]8O)[C@@H](O)[C@@H]7O.OC[C@H]9O[C@@](CO)(O[C@H]%10O[C@H](CO)[C@@H](O)[C@H](O)[C@H]%10O)[C@@H](O)[C@@H]9O
InChI
InChIKey=MQBDAEHWGRMADS-XNHLMZCASA-M
InChI=1S/5C12H22O11.C6H12O7.2Fe.Na.3O/c5*13-1-4-6(16)8(18)9(19)11(21-4)23-12(3-15)10(20)7(17)5(2-14)22-12;7-1-2(8)3(9)4(10)5(11)6(12)13;;;;;;/h5*4-11,13-20H,1-3H2;2-5,7-11H,1H2,(H,12,13);;;;;;/q;;;;;;2*+3;+1;3*-2/p-1/t5*4-,5-,6-,7-,8+,9-,10+,11-,12+;2-,3-,4+,5-;;;;;;/m111111....../s1
Molecular Formula | Na |
Molecular Weight | 22.9898 |
Charge | 1 |
Count |
|
Stereochemistry | ACHIRAL |
Additional Stereochemistry | No |
Defined Stereocenters | 0 / 0 |
E/Z Centers | 0 |
Optical Activity | NONE |
Molecular Formula | Fe |
Molecular Weight | 55.845 |
Charge | 3 |
Count |
|
Stereochemistry | ACHIRAL |
Additional Stereochemistry | No |
Defined Stereocenters | 0 / 0 |
E/Z Centers | 0 |
Optical Activity | NONE |
Molecular Formula | C6H8O7 |
Molecular Weight | 192.1235 |
Charge | -4 |
Count |
|
Stereochemistry | ABSOLUTE |
Additional Stereochemistry | No |
Defined Stereocenters | 4 / 4 |
E/Z Centers | 0 |
Optical Activity | UNSPECIFIED |
Molecular Formula | C12H22O11 |
Molecular Weight | 342.2965 |
Charge | 0 |
Count |
|
Stereochemistry | ABSOLUTE |
Additional Stereochemistry | No |
Defined Stereocenters | 9 / 9 |
E/Z Centers | 0 |
Optical Activity | UNSPECIFIED |
Molecular Formula | HO |
Molecular Weight | 17.0073 |
Charge | -1 |
Count |
|
Stereochemistry | ACHIRAL |
Additional Stereochemistry | No |
Defined Stereocenters | 0 / 0 |
E/Z Centers | 0 |
Optical Activity | NONE |
DescriptionSources: https://books.google.ru/books?id=vxtxWneRBN4C&pg=PA1103v=onepage&q&f=falsehttps://mistralhowto.wordpress.com/2012/03/12/what-is-pigment-yellow-42-and-what-is-it-used-for/ | http://sensientfoodcolors.com/en-us/confection/iron-oxides-approved-by-the-fda/ | https://www.accessdata.fda.gov/scripts/cdrh/cfdocs/cfCFR/CFRSearch.cfm?fr=73.2250 | https://www.drugs.com/inactive/ferric-oxide-yellow-381.htmlhttp://www.mfc.co.jp/english/eng/product/sanferol/pdf/fls_gras_notice.pdfhttps://www.accessdata.fda.gov/drugsatfda_docs/nda/2014/205874Orig1s000PharmR.pdfhttps://cameochemicals.noaa.gov/chemical/3468 | https://www.ncbi.nlm.nih.gov/pubmed/2135524http://www.edta-chelate.com/ferric-ammonium-edta-liquid--1640836.htmlhttps://books.google.ru/books?id=3hLmyma2-MsC&pg=PA241&lpg=PA241&dq=FERRIC+AMMONIUM+CHLORIDE retrieved from A Consumer's Dictionary of Cosmetic Ingredients, 7th Edition: Complete Information About the Harmful and Desirable Ingredients Found in Cosmetics and Cosmeceuticals By Ruth Winterhttps://www.ncbi.nlm.nih.gov/pubmed/27995746 | http://onlinelibrary.wiley.com/doi/10.1002/047084289X.rn01568/abstract?userIsAuthenticated=false&deniedAccessCustomisedMessage=Curator's Comment: description was created based on several sources, including
http://www.mfc.co.jp/english/eng/product/sanferol/index.html
Sources: https://books.google.ru/books?id=vxtxWneRBN4C&pg=PA1103v=onepage&q&f=falsehttps://mistralhowto.wordpress.com/2012/03/12/what-is-pigment-yellow-42-and-what-is-it-used-for/ | http://sensientfoodcolors.com/en-us/confection/iron-oxides-approved-by-the-fda/ | https://www.accessdata.fda.gov/scripts/cdrh/cfdocs/cfCFR/CFRSearch.cfm?fr=73.2250 | https://www.drugs.com/inactive/ferric-oxide-yellow-381.htmlhttp://www.mfc.co.jp/english/eng/product/sanferol/pdf/fls_gras_notice.pdfhttps://www.accessdata.fda.gov/drugsatfda_docs/nda/2014/205874Orig1s000PharmR.pdfhttps://cameochemicals.noaa.gov/chemical/3468 | https://www.ncbi.nlm.nih.gov/pubmed/2135524http://www.edta-chelate.com/ferric-ammonium-edta-liquid--1640836.htmlhttps://books.google.ru/books?id=3hLmyma2-MsC&pg=PA241&lpg=PA241&dq=FERRIC+AMMONIUM+CHLORIDE retrieved from A Consumer's Dictionary of Cosmetic Ingredients, 7th Edition: Complete Information About the Harmful and Desirable Ingredients Found in Cosmetics and Cosmeceuticals By Ruth Winterhttps://www.ncbi.nlm.nih.gov/pubmed/27995746 | http://onlinelibrary.wiley.com/doi/10.1002/047084289X.rn01568/abstract?userIsAuthenticated=false&deniedAccessCustomisedMessage=
Curator's Comment: description was created based on several sources, including
http://www.mfc.co.jp/english/eng/product/sanferol/index.html
Ferric bromide, red-brown odorless compound, an oxidizing reagent, used as a catalyst for organic reactions, particularly in bromination of aromatic compounds.
Approval Year
Targets
Primary Target | Pharmacology | Condition | Potency |
---|---|---|---|
Target ID: GO:0006927 Sources: https://www.ncbi.nlm.nih.gov/pubmed/21121365 |
|||
Target ID: CHEMBL2364184 |
Conditions
Condition | Modality | Targets | Highest Phase | Product |
---|---|---|---|---|
Primary | Unknown Approved UseUnknown |
|||
Primary | SANFEROL Approved UseIt has also been reported that SFC preparation improved iron deficiency in a pregnant woman with iron deficiency anemia whose hemoglobin level had not increased after administration of other iron preparations such as ferrous fumarate. A dairy supplemental dose of SFC improved iron deficiency in young women with iron deficiency. |
|||
Inactive ingredient | Oxycontin Approved UseOxyContin is used in the treatment of chronic pain; pain and belongs to the drug class narcotic analgesics. Launch Date9.0935997E11 |
|||
Curative | RADIOGARDASE Approved UseInsoluble Prussian blue is indicated for treatment of patients with known or suspected internal contamination with radioactive cesium and/or radioactive or non-radioactive thallium to increase their rates of elimination. Launch Date1.06496642E12 |
|||
Palliative | AURYXIA Approved UseFerric Citrate is a phosphate binder indicated for the control of serum phosphorus levels in patients with chronic kidney disease on dialysis. Launch Date1.40978881E12 |
PubMed
Title | Date | PubMed |
---|---|---|
The formation of ferritin from apoferritin. Catalytic action of apoferritin. | 1973 Oct |
|
The absorption of iron as supplements in infant cereal and infant formulas. | 1975 May |
|
Contact dermatitis to yellow iron oxide. | 1985 Aug |
|
Carcinogenicity studies on natural and man-made fibres with the intraperitoneal test in rats. | 1989 |
|
Effect of physical exercise and vitamin C on absorption of ferric sodium citrate. | 1996 Dec |
|
New phosphate binding agents: ferric compounds. | 1999 Jun |
|
Non-invasive and non-destructive micro-XRF and micro-Raman analysis of a decorative wallpaper from the beginning of the 19th century. | 2007 Feb |
|
Interaction of omapatrilat with FD&C Blue No. 2 lake during dissolution of modified release tablets. | 2007 Jul 18 |
|
Oxidative aromatic C-N bond formation: convenient synthesis of N-amino-3-nitrile-indoles via FeBr3-mediated intramolecular cyclization. | 2011 May 21 |
|
Microwave assisted convenient one-pot synthesis of coumarin derivatives via Pechmann condensation catalyzed by FeF3 under solvent-free conditions and antimicrobial activities of the products. | 2014 Aug 26 |
|
FeF(3) catalyzed cascade C-C and C-N bond formation: synthesis of differentially substituted triheterocyclic benzothiazole functionalities under solvent-free condition. | 2014 May |
|
Halide Influence on Molecular and Supramolecular Arrangements of Iron Complexes with a 3,5-Bis(2-Pyridyl)-1,2,4,6-Thiatriazine Ligand. | 2016 Jun 6 |
|
Iron-Catalyzed Regioselective Transfer Hydrogenative Couplings of Unactivated Aldehydes with Simple Alkenes. | 2016 May 17 |
|
A Simplified Fe-Based PhotoATRP Using Only Monomers and Solvent. | 2017 Jul |
Sample Use Guides
In Vivo Use Guide
Sources: https://www.ncbi.nlm.nih.gov/pubmed/165454
Curator's Comment: Iron oxides black, red and yellow are intended to be used as colourants in feedingstuffs for all animal species without dose or age restriction. The applicant recommends 500–1,200 mg/kg of the additives in complete (and complementary) feedingstuffs as standard dose. http://onlinelibrary.wiley.com/doi/10.2903/j.efsa.2016.4482/full
As a food supplement, ferric sodium pyrophosphate is administered orally.
Route of Administration:
Oral
Substance Class |
Chemical
Created
by
admin
on
Edited
Fri Dec 16 18:58:47 UTC 2022
by
admin
on
Fri Dec 16 18:58:47 UTC 2022
|
Record UNII |
CC9149U2QX
|
Record Status |
Validated (UNII)
|
Record Version |
|
-
Download
Name | Type | Language | ||
---|---|---|---|---|
|
Official Name | English | ||
|
Common Name | English | ||
|
Brand Name | English | ||
|
Common Name | English | ||
|
Common Name | English | ||
|
Common Name | English | ||
|
Common Name | English | ||
|
Common Name | English | ||
|
Common Name | English | ||
|
Common Name | English | ||
|
Brand Name | English | ||
|
Common Name | English | ||
|
Common Name | English | ||
|
Common Name | English | ||
|
Common Name | English | ||
|
Common Name | English | ||
|
Brand Name | English | ||
|
Common Name | English | ||
|
Common Name | English |
Classification Tree | Code System | Code | ||
---|---|---|---|---|
|
NDF-RT |
N0000177913
Created by
admin on Fri Dec 16 18:58:47 UTC 2022 , Edited by admin on Fri Dec 16 18:58:47 UTC 2022
|
||
|
NDF-RT |
N0000006237
Created by
admin on Fri Dec 16 18:58:47 UTC 2022 , Edited by admin on Fri Dec 16 18:58:47 UTC 2022
|
||
|
NDF-RT |
N0000006237
Created by
admin on Fri Dec 16 18:58:47 UTC 2022 , Edited by admin on Fri Dec 16 18:58:47 UTC 2022
|
||
|
NDF-RT |
N0000006237
Created by
admin on Fri Dec 16 18:58:47 UTC 2022 , Edited by admin on Fri Dec 16 18:58:47 UTC 2022
|
Code System | Code | Type | Description | ||
---|---|---|---|---|---|
|
34089-81-1
Created by
admin on Fri Dec 16 18:58:47 UTC 2022 , Edited by admin on Fri Dec 16 18:58:47 UTC 2022
|
NON-SPECIFIC STOICHIOMETRY | |||
|
C77274
Created by
admin on Fri Dec 16 18:58:47 UTC 2022 , Edited by admin on Fri Dec 16 18:58:47 UTC 2022
|
PRIMARY | |||
|
DB09517
Created by
admin on Fri Dec 16 18:58:47 UTC 2022 , Edited by admin on Fri Dec 16 18:58:47 UTC 2022
|
PRIMARY | |||
|
CC9149U2QX
Created by
admin on Fri Dec 16 18:58:47 UTC 2022 , Edited by admin on Fri Dec 16 18:58:47 UTC 2022
|
PRIMARY | |||
|
Sodium Ferric Gluconate Complex
Created by
admin on Fri Dec 16 18:58:47 UTC 2022 , Edited by admin on Fri Dec 16 18:58:47 UTC 2022
|
PRIMARY | |||
|
SUB13850MIG
Created by
admin on Fri Dec 16 18:58:47 UTC 2022 , Edited by admin on Fri Dec 16 18:58:47 UTC 2022
|
PRIMARY | |||
|
SUB20743
Created by
admin on Fri Dec 16 18:58:47 UTC 2022 , Edited by admin on Fri Dec 16 18:58:47 UTC 2022
|
PRIMARY | |||
|
DTXSID80187686
Created by
admin on Fri Dec 16 18:58:47 UTC 2022 , Edited by admin on Fri Dec 16 18:58:47 UTC 2022
|
PRIMARY | |||
|
CHEMBL1201494
Created by
admin on Fri Dec 16 18:58:47 UTC 2022 , Edited by admin on Fri Dec 16 18:58:47 UTC 2022
|
PRIMARY | |||
|
261435
Created by
admin on Fri Dec 16 18:58:47 UTC 2022 , Edited by admin on Fri Dec 16 18:58:47 UTC 2022
|
PRIMARY | RxNorm | ||
|
KK-97
Created by
admin on Fri Dec 16 18:58:47 UTC 2022 , Edited by admin on Fri Dec 16 18:58:47 UTC 2022
|
PRIMARY | |||
|
C1505
Created by
admin on Fri Dec 16 18:58:47 UTC 2022 , Edited by admin on Fri Dec 16 18:58:47 UTC 2022
|
CONCEPT | Dietary Supplement | ||
|
Sodium ferric gluconate complex
Created by
admin on Fri Dec 16 18:58:47 UTC 2022 , Edited by admin on Fri Dec 16 18:58:47 UTC 2022
|
PRIMARY | |||
|
CC9149U2QX
Created by
admin on Fri Dec 16 18:58:47 UTC 2022 , Edited by admin on Fri Dec 16 18:58:47 UTC 2022
|
PRIMARY | |||
|
M10021
Created by
admin on Fri Dec 16 18:58:47 UTC 2022 , Edited by admin on Fri Dec 16 18:58:47 UTC 2022
|
PRIMARY | Merck Index | ||
|
76968835
Created by
admin on Fri Dec 16 18:58:47 UTC 2022 , Edited by admin on Fri Dec 16 18:58:47 UTC 2022
|
PRIMARY |
Related Record | Type | Details | ||
---|---|---|---|---|
|
PARENT -> SALT/SOLVATE | |||
|
PARENT -> SALT/SOLVATE |
Related Record | Type | Details | ||
---|---|---|---|---|
|
ACTIVE MOIETY |